The global lancets market size was valued at USD 5.90 billion in 2024 and is projected to reach USD 9.15 billion by 2030, growing at a CAGR of 7.7% from 2025 to 2030. The growth of this market is primarily driven by the increasing prevalence of diabetes, coupled with the rising proportion of the geriatric population, who are more susceptible to developing the disease. These factors are creating a steady demand for lancets, which are essential tools for diabetes management and self-monitoring of blood glucose levels.
In addition to diabetes prevalence, other factors such as the rising incidence of infectious diseases, growing awareness regarding advanced diabetes treatment options, and an increasing focus on homecare solutions are contributing to the market expansion. According to the IDF Diabetes Atlas, around 37 million adults worldwide—equivalent to one in ten people—were living with diabetes in 2021. This number is projected to grow to approximately 643 million by 2030 and 783 million by 2045, highlighting a significant increase in the population requiring diabetes management tools such as lancets.
Furthermore, demographic trends are expected to further boost market demand. World Health Organization (WHO) data indicates that the global population aged 60 and above is projected to rise to 1.4 billion by 2030 and 2.1 billion by 2050. Aging is associated with a natural decline in insulin secretion and an increase in insulin resistance, both of which contribute to a higher risk of developing diabetes among older adults. An article published by the Endocrine Society in January 2022 notes that approximately 33% of adults aged 65 and older are living with diabetes. This growing geriatric population, combined with their heightened susceptibility to diabetes, is expected to drive the demand for lancets and other diabetes management solutions over the forecast period.
Key Market Trends & Insights:
• In 2024, the North American lancets market accounted for the largest revenue share of 36.4% globally, establishing the region as a key contributor to the overall market. The region’s leadership can be attributed to the presence of well-established healthcare infrastructure, advanced medical technologies, high awareness regarding diabetes management, and significant adoption of homecare solutions for chronic disease monitoring.
• Within North America, the U.S. lancets market held a dominant position in 2024. This dominance is driven by factors such as a high prevalence of diabetes, growing adoption of self-monitoring devices, and strong healthcare support systems. The country also benefits from a large base of technologically advanced medical device manufacturers, which facilitates the availability of innovative and high-quality lancet products to meet consumer needs.
• Based on type, the safety lancets segment commanded the largest market share of 56.4% in 2024. Safety lancets are widely preferred due to their built-in protective features that reduce the risk of accidental needle-stick injuries, ensure hygienic use, and are suitable for both hospital and home settings. Their ease of use, reliability, and compliance with safety regulations have contributed significantly to their widespread adoption.
• By application, the blood glucose testing segment accounted for the largest share of 41.1% in 2024. This is primarily due to the high demand for regular blood glucose monitoring among diabetes patients. Blood glucose testing is critical for effective diabetes management, enabling patients and healthcare providers to monitor glucose levels and make timely adjustments to treatment plans. The convenience and accessibility of lancets for frequent self-testing have further strengthened this segment’s market position.
• In terms of end-use, the hospitals and clinics segment dominated the market in 2024. Healthcare facilities rely heavily on lancets for patient diagnostics and routine blood testing due to their reliability, accuracy, and standardized usage. The high patient turnover in hospitals and clinics, coupled with the need for safe and efficient blood sampling methods, continues to drive the demand for lancets in these settings, making this segment a significant contributor to the overall market revenue.
Order a free sample PDF of the Lancets Market Intelligence Study, published by Grand View Research.
Market Size & Forecast:
• 2024 Market Size: USD 5.90 Billion
• 2030 Projected Market Size: USD 9.15 Billion
• CAGR (2025-2030): 7.7%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market
Key Companies & Market Share Insights:
Several key companies are actively operating in the global lancets market, including BD, Roche Diagnostics, Medline Industries, LP., MTD Medical Technology and Devices, B. Braun SE, and Terumo Medical Corporation. These players maintain a strong market presence by focusing on developing advanced and innovative products, expanding their global footprint, and pursuing strategic initiatives such as mergers and acquisitions. Such strategies enable these companies to strengthen their competitive positions, enhance product portfolios, and meet the growing demand for safe and effective diabetes management solutions.
BD (Becton, Dickinson and Company) is a leading global medical technology firm with operations spanning multiple healthcare segments, including diabetes care, medication management, infection prevention, and diagnostics. Within the lancets segment, BD offers a variety of products, including the BD Microtainer contact-activated lancet, which is designed for safe and efficient blood collection via fingerstick. These products are widely used in both clinical settings and at-home monitoring, reflecting BD’s commitment to enhancing patient safety and convenience.
Roche Diagnostics is another prominent player, recognized globally for its comprehensive range of medical tests and digital healthcare solutions that assist healthcare professionals in diagnosing and managing diseases effectively. The company’s lancet offerings include products such as the ACCU-CHEK Safe-T-Pro Plus Lancet, which provides a reliable and safe option for blood sampling. Roche’s focus on combining innovation with user-friendly design ensures high accuracy, safety, and ease of use, making its lancets popular among both healthcare providers and patients.
Key Players
• BD
• Roche Diagnostics
• Medline Industries, LP.
• EQT AB
• MTD Medical Technology and Devices
• B. Braun SE
• Terumo Medical Corporation
• Owen Mumford
• Arkray
• AgaMatrix
• Nipro Europe Group Companies
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion:
The global lancets market is experiencing significant growth, driven by several key factors. The increasing prevalence of diabetes and the rising geriatric population are major contributors to this expansion. Additionally, the growing incidence of infectious diseases and heightened awareness about advanced diabetes treatments are further propelling market demand. The emphasis on homecare solutions has also played a pivotal role in boosting the market.
